Medical News

RSS

Rising colorectal cancer rates in young Swiss adults spark concern

While the incidence of colorectal cancer is decreasing among those over 50, it is rising at an alarming rate among younger individuals, sometimes as early as their thirties.

21 Apr 2026

Democrats demand Trump administration halt plan to collect federal workers’ health data

Democratic lawmakers are demanding that the Trump administration halt plans to collect sensitive medical records for millions of federal workers and retirees, as well as their family members.

21 Apr 2026

AI chatbots give misleading health advice nearly half the time

Widespread inaccuracies in AI chatbot health responses pose public health risks, highlighting the urgent need for better oversight and cleaner training data.

21 Apr 2026

Alzheimer’s monoclonal antibodies fail to deliver meaningful results

Despite reducing amyloid plaques, antibody treatments for Alzheimer's fail to improve cognition, highlighting critical gaps in current therapeutic approaches.

21 Apr 2026

Last patient has completed AlzeCure's Phase Ib clinical study with NeuroRestore ACD856

AlzeCure Pharma AB (publ), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the last patient’s last visit (LPLV) has now occurred in the ongoing Phase Ib clinical trial of ACD856, the lead drug candidate within the NeuroRestore platform, which is being developed for Alzheimer’s disease and other indications.

From AlzeCure Pharma AB 21 Apr 2026

Long-term exposure to air pollution (PM2.5) raises risk of developing cancer by 11 % and of dying from cancer by 12 %

The Union for International Cancer Control (UICC), with support from the Clean Air Fund, has released a global report, Clean air in cancer control: An overview of the evidence, presenting data on the scale of cancer risk and mortality from polluted air.

21 Apr 2026

New UWB technique helps pill-sized cameras overcome human body interference

Diagnostic tests for stomach conditions are tough for patients, as many of the most accurate ones involve minor surgical procedures or invasive techniques.

21 Apr 2026

DNA methylation "fingerprints" identify primary sites in metastatic cancers

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

21 Apr 2026

Ibuprofen shown to improve cognitive function in patients undergoing chemotherapy

Researchers have already shown that mild to moderate exercise can reduce "chemo brain," and a new study suggests that a low dose of an over-the-counter anti-inflammatory, ibuprofen, can also achieve positive results for cancer patients.

21 Apr 2026

Early genomic testing prevents years of inconclusive visits for pediatric patients

For many families, eight years of uncertainty meant repeated specialist visits, inconclusive genetic tests and the growing fear that a clear answer might never come. For nearly half of the children enrolled in the Telethon Undiagnosed Disease Program (TUDP), that wait is now over.

21 Apr 2026

Clinical study confirms women's symptoms are de-prioritized in healthcare

Women have described being dismissed, disbelieved and left in serious pain during a routine womb examination that affects tens of thousands every year.

21 Apr 2026

Heatwaves above 38 °C significantly spike cardiovascular cases in middle-aged populations

A novel study has revealed a link between extreme weather and the risk of cardiovascular disease among middle-aged and older adults in 157 Chinese cities. Based on a city's climate and location, exposure to extreme heat, cold, and precipitation each increases the risk of heart disease. The findings of the study in the American Journal of Preventive Medicine, published by Elsevier, provide evidence for policymakers across different regions to develop targeted strategies protecting vulnerable populations during extreme climate events.

21 Apr 2026

Phase I NSCLC trials shrink and cluster in major U.S. cities

Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly concentrated at the top 20 highest‑volume clinical trial sites largely located in major cities, according to results presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

21 Apr 2026

Multimodal AI improves prediction of PIK3CA mutations in breast cancer

Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway are prevalent in its development.

21 Apr 2026

Muscle energy recovery may explain fatigue in cancer survivors

Even apparently healthy cancer survivors often complain of extreme fatigue. They have finished treatment, the scans are clear, but they feel hollowed out, unable to walk to the mailbox or stay awake through dinner.

21 Apr 2026

Study reveals the physics behind neural tube closure in embryos

In about one out of every 1,000 pregnancies, the neural tube, a key nervous system structure, fails to close properly.

21 Apr 2026

Study reveals rising knife deaths among young teens in England

The average age of a young fatal stab victim is now 14, indicates an analysis of the causes of death among children and teens in England between 2019 and 2024, published online in Emergency Medicine Journal.

20 Apr 2026

APC-deficient cancer cells rely on single enzyme for survival

A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival, revealing a potential strategy for selectively targeting tumours associated with one of the most common mutations in colorectal cancer.

20 Apr 2026

Trial shows safety of novel KIR-CAR T therapy in solid tumors

An innovative type of CAR T cell therapy, called KIR-CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine patients with advanced ovarian cancer, mesothelioma or cholangiocarcinoma (bile duct cancer), according to an early report from an ongoing Phase I dose-escalation clinical trial.

20 Apr 2026

Microbial "signatures" within the oral cavity and gut may aid in gastric cancer detection

A recent study published in Cell Reports Medicine has identified distinct microbial "signatures" within the oral cavity and gut that serve as robust biomarkers for the early detection of gastric cancer (GC).

20 Apr 2026